WOODLAND HILLS, CA / ACCESSWIRE / November 29, 2021 /BMCS SUMCOIN INDICATIVE FUND, INC doing business like BioTech Medics, Inc stock symbol BMCS still awaiting the announcement of the name change, is pleased to launch its new website (www.bmcssumcoin.com) and business plan in the digital asset market.
According to Anthony K. Miller, CEO, “For months our company has been anticipating these events which are being announced today, and now it is time to move forward on our mission to enter the digital asset industry. To date, we have built our Delaware Statutory Trust. , builds the architecture of our company Plan and build an amazing team (which will continue to grow) to bring us into this new chapter in the history of this company Today we are launching our company website which provides information on this new direction of our business.We are continually accumulating assets under management which now total over $ 40 million and our consignment assets are extremely important. BMCS has a formidable business model that is modeled after other companies in this digital asset market. Our goal is to make Sumcoin as liquid as other currencies in this digital ecosystem. We have also filed a Reg D 506c with the SEC and will immediately begin raising capital with this exemption to grow our business model and build assets and share value for our investors and add Sumcoin on as many exchanges as needed for awareness and liquidity.
Our business plan offers investors the opportunity to participate in this industry by investing in common stocks representing a currency: Sumcoin (the world’s first index coin). Sumcoin is a crypto blockchain using a scrypt proof-of-work algorithm. Sumcoin tracks all digital coins in real time and its price is an aggregate or “SUM” of the 100 most valuable coins by market cap. Our plan is to provide a solution for those who want to gain maximum exposure in the digital space (without having to learn the intricacies of this new industry) but who only want to own “a digital asset” for the sake of simplicity, we believe The BMCS Sumcoin Index Fund is that solution.
Today we are starting a smooth launch of our business plan and in the coming weeks we will have a more robust project launch to a wider audience. I invite all of you to visit our website at www.bmcssumcoin.com to better understand our mission and our business model; commented Miller “
LEARN MORE ABOUT SUMCOIN:https://www.sumcoin.org/
About the BMCS SUMCOIN INDEX FUND / BioTech Medics, Inc, a Wyoming publicly traded company traded over the counter under the ticker symbol BMCS-OTC located in Los Angeles California. BMCS has always been a biotechnology company, but now a “Digital assets firm “ focusing on Sumcoin (the world’s first indexed currency), one of the most important currencies in the world.
Forward-looking statements: This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those regarding expected plans of BioTech Medics, Inc., and related companies. All statements included in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements involve risks, assumptions, uncertainties and other known and unknown factors. Future statements and statements using words such as “may,” may “,” could “,” should “,” predict “,” aim “,” “” “” intention “,” objective “,” estimate “, “Expect”, “expectations”, “project”, “projections”, “plans”, “anticipate”, “believe”, “think”, “confident” “planned” or similar expressions are intended to identify statements Forward-looking statements are not guarantees of performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and are beyond our control.
These risks and uncertainties could cause actual results to differ materially from those expressed or implied by forward-looking statements, and therefore should be carefully considered. You should take into account the risk areas described in any forward-looking statements that may be made in this document. We caution you not to place undue reliance on forward-looking statements, which speak only as of the date of this report, and readers should carefully consider this report in its entirety. We disclaim any obligation to update any of these forward-looking statements as a result of new information, future events or otherwise, except as expressly required by law. Further information on our risk factors is contained in our filings with the OTC markets and the SEC website. Any forward-looking statements we make here speak only as of the date on which they are made. Factors or events that could cause our actual results to vary may occur from time to time, and we cannot predict all of them. We assume no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.
RELATIONS WITH INVESTORS
STOCK SYMBOL: (BMCS-OTC)
EMAIL: [email protected]
LOCATION: WOODLAND HILLS, CA.
THE SOURCE: BioTech Medics Inc / BMCS SUMCOIN INDEX FUND
See the source version on accesswire.com: